EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.1.3.9 | Ataxia Telangiectasia |
6432389 |
Defective interferon-gamma production in ataxia-telangiectasia. |
therapeutic application
unassigned |
2
0 |
| 1.1.3.9 | Carcinoma |
6299058 |
Cell surface glycoprotein patterns of cell lines derived from human small cell carcinoma of the lung. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 1.1.3.9 | Carcinoma |
7506904 |
Expression of the tumor marker D-galactose-beta-[1-->3]-N-acetyl-D-galactosamine by premalignant and malignant prostate. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 1.1.3.9 | Carcinoma |
9085164 |
Histochemical and immunohistochemical study of human gastric carcinoma differentiation with special reference to supplementary role for endosonography in evaluating depth of invasion. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 1.1.3.9 | Carcinoma, Hepatocellular |
194981 |
Increased binding and killing of neuraminidase-galactose oxidase-treated tumor cells by normal macrophages. |
causal interaction
ongoing research
unassigned |
3
2
0 |
| 1.1.3.9 | Carcinoma, Small Cell |
6299058 |
Cell surface glycoprotein patterns of cell lines derived from human small cell carcinoma of the lung. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 1.1.3.9 | Cholera |
544939 |
Isolation of cholera toxin receptors from a mouse fibroblast and lymphoid cell line by immune precipitation. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
3
3
1 |
| 1.1.3.9 | Cholera |
6997109 |
Correlation between macrophages and their membrane fraction. Cytocidal activities on neoplastic cells. |
causal interaction
unassigned |
2
0 |
| 1.1.3.9 | Colonic Neoplasms |
1332646 |
Detection of the tumor marker D-galactose-beta-(1-->3)-N-acetyl-D-galactosamine in colonic cancer and precancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
1
2
0 |
| 1.1.3.9 | Colorectal Neoplasms |
7805025 |
Common expression of the tumor marker D-galactose-beta-[1-->3]-N-acetyl-D-galactosamine by different adenocarcinomas: evidence of field effect phenomenon. |
diagnostic usage
unassigned |
3
0 |
